Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients

NCT03872141 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03872141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03872141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients
Lead sponsor
Yale University
Phase
Observational
Overall status
Completed
Start date
May 23, 2017
Completion date
February 25, 2021
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy induced peripheral neuropathy, paclitaxel induced neuropathy